The ASX share market could be the most bountiful place to generate a good yield from passive investment income.

Term deposits are now offering a better interest rate. But, while they do offer protection, I think a downside is that they can’t organically generate a higher return. Term deposits don’t generate profit that can grow.

But, with businesses, they can grow profit. Companies can decide to pay out some of the annual profit each year as a dividend and use the rest to generate more growth.

Different businesses have different yields. Some yields are so large that they can generate a lot of passive income from a relatively small investment.

Generate $140 every month

There are very few investments that pay dividends every single month. A lot of ASX dividend shares pay dividends every six months or every three months.

But, we can think of $140 per month in annual terms – it’s $1,680 each year.

I’m not about to say that earning $1,680 from a $5,000 investment is a good idea, or even possible. That would represent a 33.6% dividend yield.

There’s a more realistic and sustainable way.

Let’s imagine we invest in a diversified portfolio of ASX dividend shares with an average dividend yield of 5%. That would be an annual passive income of $250. Re-investing those dividends into more ASX dividend shares with a 5% dividend yield would make an extra $12.50 of dividends, meaning $262.50.

Continuing re-investing those dividends every year means the power of compounding can really boost the annual income. If the dividends from the businesses themselves don’t grow, then after five years it could be just over $300 of annual dividends, in 10 years it’s $388 of dividends, after 20 years it’s $632 of annual dividends and after 40 years it would be around $1,680.

But, let’s keep in mind that many businesses ­do grow their dividends. It’s impossible to say what the coming decades have in store. If a business pays a dividend yield of 5%, we re-invest those dividends and it grows the dividend by 5% each year, which means the annual dividends would increase by around 10% per annum.

So, if we assume a portfolio of ASX dividend shares grows their dividend by 5% per annum, we re-invest the dividends (and also acknowledge that the cost of buying more shares rises over time in this calculation), we could receive over $11,000 of annual dividends each year after 40 years, just from that initial $5,000 investment.

Foolish takeaway

I think that ASX dividend shares like Wesfarmers Ltd (ASX: WES) are a great source of passive income. There are loads of resources on The Motley Fool website about which ASX dividend shares could be good investments to own.

The post Need passive income? Turn $5,000 into $140 every month appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why this ASX 200 ‘stable stock’ is poised to outperform: Goldman Sachs
• Down 60% in 12 months, I’d buy these 2 ASX All Ords shares for the turnaround
• Is Woolworths ‘the granddaddy of recession-proof stocks’?
• The BHP share price is taking off today. Could this be why?
• Here’s how much I would need to invest in Fortescue shares to generate a $150 monthly income

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/8X3PI7e

S&P/ASX 200 Index (ASX: XJO) healthcare share ResMed Inc (ASX: RMD) counts among a select basket of stable stocks that Goldman Sachs believes is set to widely outperform the benchmark.

The company is listed on multiple international exchanges. It focuses on treating a range of sleeping disorders and has seen some sizeable swings its share price over the past year, leaving it right about where it was 12 months ago.

But the ASX 200 medical stock could enjoy a far stronger year ahead.

14% potential share price upside for ResMed

According to analysts at Goldman Sachs, stocks with stable earnings growth and share prices have historically tended to outperform when the economy is slowing. But we’ve yet to see that with Goldman’s basket of stable stocks, which includes ResMed.

“Our economists see greater downside risks than upside risks, suggesting ample opportunities for stable stocks to outperform,” the analysts said (courtesy of The Australian Financial Review.)

The broker said that despite the economic slowdown hitting developed nations, stables stocks — like ASX 200 listed ResMed — are trading at “undemanding valuations”.

There are no guarantees in the world of investing. But Goldman sees a positive risk-reward trade-off with ResMed shares.

The main risk to owning stable stocks is if economic growth proves to be more resilient than we expect,” the broker said. “But low valuations, poor recent performance, and elevated recession risk mean the risk/reward is asymmetric.”

In its recent report profiling a range of ASX 200 healthcare stocks, Goldman noted:

We continue to express a general preference for the device/drug names over the service providers in the current environment, on the basis of: i) stronger pricing power; ii) more assured volume profiles; iii) more resilient/expanding market shares; and iv) stronger balance sheets.

As for ResMed specifically, the analysts said, “As operational pressures continue to ease we see margin/cost dynamics improving, both near and long-term.”

Goldman is expecting “a sequentially stronger 2H23” for the ASX 200 medical device stock. The analysts forecast an earnings per share compound annual growth rate of 11% over the next three years “with potential upside depending on how competitive dynamics develop”.

Sharper-than-expected competitor recovery and potentially new disruptive therapies are the key risks to this outlook.

Goldman has a buy rating on ResMed shares with a target price of $38.00. That’s 13.8% above the current share price.

How has this ASX 200 stable stock been tracking?

As you can see in the chart below, the ResMed share price is just about flat over the past 12 months. So far in 2023, the ASX 200 stable stock has gained 7.8%.

The post <strong>Why this ASX 200 ‘stable stock’ is poised to outperform: Goldman Sachs</strong> appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Build your portfolio around these ASX 200 blue chip shares: brokers
• My top 5 ASX shares to buy and hold forever in anticipation of the bull market
• The broker community’s 3 best ASX 200 shares to buy for 2023
• The ASX sector set to boom no matter what happens this year
• Buy these 2 ASX health-tech shares that are ready to rocket: Wilson

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/ZNV4lv8

The ASX share market has been through a lot of ups and downs over the past year. I think some of the beaten-up S&P/ASX All Ordinaries Index (ASX: XAO) shares, could be excellent opportunities for a turnaround.

I think that trying to be contrarian can be a dangerous play if investors go for the wrong businesses.

However, I believe that some ASX All Ords shares are primed to rediscover their lost form as better times return, hopefully.

It’s worth noting that just because something has fallen doesn’t necessarily mean that it’s going to quickly recover to the former price. Anchoring past prices can be an ill-advised thought.

With these two names, I believe we’re being presented with appealing, temporarily-lower valuations.

Australian Ethical Investment Ltd (ASX: AEF)

Over the past year, the Australian Ethical share price has declined by around 60%.

The ethically-focused fund manager has seen its valuation sink since November 2021 – it’s actually down by around 80% from that high point.

There are some factors that explain the difficulties. Volatility hurt share market returns, which consequently impacted the growth potential of Australian Ethical’s organic funds under management (FUM).

In the first half of FY23, it only saw $0.19 billion of positive net inflows, excluding the impact of the Christian Super FUM. But, it’s the Christian Super FUM that could help drive earnings higher after a 21% increase in FUM to $8.37 billion.

But, there were costs to taking on the Christian Super members, which hurt profitability in the short term.

However, I think the ASX All Ords share can recover as investment markets start showing signs of a rebound, and the fund manager attracts more members and benefits from regular superannuation contributions.

The company is expecting operating leverage to emerge towards the end of FY24, which I think could assist in a pleasing recovery for the Australian Ethical share price.

Baby Bunting Group Ltd (ASX: BBN)

The Baby Bunting share price has also fallen by around 60% in the past year. The ASX retail share has been going through a tricky period as competitors have been discounting prices and Baby Bunting has been obliged to compete with that.

This led to a 60% decline in underlying net profit after tax (NPAT) to $5.1 million for the All Ords ASX share and a 67% fall in statutory net profit to $2.7 million.

However, the company reported that its gross profit margin was recovering and that it was expecting to make underlying NPAT of between $21.5 million to $24 million.

I believe that a combination of more stores, the Baby Bunting marketplace, the expansion in New Zealand and an improvement in profit margins will enable a recovery of the Baby Bunting share price.

According to Commsec, the Baby Bunting share price is valued at under 9 times FY25’s estimated earnings, with a possible grossed-up dividend yield of 11%.

The post Down 60% in 12 months, I’d buy these 2 ASX All Ords shares for the turnaround appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Bargain hunting: 3 retailer ASX shares that shouldn’t be this cheap
• Australian Ethical just dumped 1.6 million shares of this ASX 200 company. Here’s why

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Australian Ethical Investment and Baby Bunting Group. The Motley Fool Australia has recommended Australian Ethical Investment and Baby Bunting Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/2sEgrMj

Woolworths Group Ltd (ASX: WOW) shares saw plenty of volatility during the COVID-19 period. But now the economy is facing uncertain times amid inflation and higher interest rates. Could Woolworths be one of the most recession-proof stocks around?

As a supermarket business, it’s understandable why investors may be looking at Woolworths shares as a defensive option because it sells food – one of the most essential products that a household needs.

We all need to eat, so even if there is a decline in economic demand for other ASX shares, I don’t think it’s likely that Woolworths will suffer the same fate.

Is Woolworths the most recession-proof ASX stock?

During the worrying times of March 2020, there was huge demand for Woolworths products. In fact, Christmas-time levels of demand.

The last year has shown that even though food prices have been going up, households have kept buying – what choice did they have?

If a recession were to occur, I think people are going to choose to buy food from Woolworths over buying a new TV, going on a holiday, buying new clothes, or other non-essential spending.

Certainly, I’d suggest that Woolworths’ earnings are less likely to fall in a recession than those of JB Hi-Fi Limited (ASX: JBH), Super Retail Group Ltd (ASX: SUL), or Nick Scali Limited (ASX: NCK).

Let’s not forget that Woolworths also owns the majority of the PETstock business – I’d guess that households will continue to spend on their furry (or non-furry) friends.

However, I’m not sure that Big W’s earnings are that defensive, even though it’s only a relatively small part of Woolworths’ overall earnings.

We could say that Coles Group Ltd (ASX: COL) has a very similar set-up to Woolworths because of its large chain of supermarkets. But, Coles has a liquor division rather than PETstock and Big W.

I think Woolworths is right up there as one of the most recession-proof ASX stocks when it comes to its earnings.

There are a few other categories and ASX shares that I might expect to continue performing, such as funeral provider Propel Funeral Partners Ltd (ASX: PFP) because of the inevitable annual demand for its services. Telco Telstra Group Ltd (ASX: TLS) and energy infrastructure business APA Group (ASX: APA) could also see strong resilience.

Recent performance

The latest we’ve heard from Woolworths has been very promising. Woolworths reported that in the first six months of FY23, sales rose 4% to $33.2 billion and underlying earnings per share (EPS) grew 11.7% to 71.9 cents.

Its financials have done well and the Woolworths share price has jumped 18% in 2023 to date. But, valuation can be a risk if the share price goes too high.

According to Commsec, Woolworths shares are valued at 28x FY23’s estimated earnings. I think the business is a good candidate for a recession-proof stock, but it doesn’t look cheap at this price considering how high interest rates are these days.

The post Is Woolworths ‘the granddaddy of recession-proof stocks’? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Top defensive ASX shares to buy in April 2023
• Investing in ASX 200 dividend shares? Here’s how I’d aim for $200 per month in passive income
• Top ASX shares to buy in April 2023
• Why did the Woolworths share price smash the ASX 200 in March?
• Analysts name 2 strong ASX shares to buy for a retirement portfolio

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Super Retail Group. The Motley Fool Australia has positions in and has recommended APA Group, Coles Group, Super Retail Group, and Telstra Group. The Motley Fool Australia has recommended JB Hi-Fi and Propel Funeral Partners. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/yUnzBCw

The BHP Group Ltd (ASX: BHP) share price is starting the week off on the right foot, leaping 1.8% to trade at $45.86 in early trading.

The S&P/ASX 200 Index (ASX: XJO) iron ore miner’s stock is taking off amid news of its planned acquisition of copper producer OZ Minerals Ltd (ASX: OZL).

For comparison, the ASX 200 is up 1.21% right now while BHP’s home sector – the S&P/ASX 200 Materials Index – is gaining 2.11%.

The takeover is one step closer to being realised after it was granted approvals from Vietnam’s competition regulator.

Let’s take a closer look at the latest from the ASX’s biggest company.

BHP copper acquisition receives regulatory approval

The BHP share price is climbing amid good news of its proposed $9.8 billion acquisition of OZ Minerals.

The pair today announced that Vietnam’s Competition and Consumer Authority has approved the takeover – leaving one less condition to be satisfied prior to its implementation.

And just in time. The acquisition will face a shareholder vote on Thursday.

If approved by investors, the court will be given the final say, with implementation then scheduled for early May.

BHP put forward a $28.25 per share bid for the copper miner in November 2022.

That offer will likely be less a $1.75 fully franked dividend OZ Minerals intends to declare, as revealed in February.

Interestingly, the OZ Minerals share price is flat this morning at $28.14 a share, the same as Thursday’s closing price.

BHP share price underperforms ASX 200 in 2023

Both stocks have underperformed the broader ASX 200 so far this year.

The index has risen 4% in 2023 so far. At the same time, BHP shares have dumped 0.6% and OZ Minerals’ have lifted 0.6%.  

Looking further back, the BHP share price is down 12.8% over the last 12 months while OZ Minerals’ stock has gained 9.3%. Meanwhile, the ASX 200 has slumped 3.2%.

The post The BHP share price is taking off today. Could this be why? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• What’s going on with BHP shares and lithium?
• Which is the best ASX 200 iron ore stock now: BHP, Fortescue, or Mineral Resources?
• Investing in ASX 200 dividend shares? Here’s how I’d aim for $200 per month in passive income
• ASX 200 rebounds after RBA hits pause on its rate hikes
• Passive income: How much to invest to get $800 per month

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/7VnkO5r

Earning monthly income from ASX dividend shares can be a good way of generating extra cash on the side.

Mining giant Fortescue Metals Group Ltd (ASX: FMG) has a strong history of paying dividends to investors.

Fortescue shares have climbed 5% in the year to date and were priced at $21.57 at last close.

How many Fortescue shares would get you to $150 a month in dividends?

Starting with the basics, a monthly income of $150 equates to an annual income of $1800.

Fortescue has paid $1.96 worth of dividends in the past year. This consists of an interim fully franked dividend of 75 cents per share in the first half of FY23, and a final fully franked dividend of $1.21 per share in the second half of FY22.

So in order to have received $1800 ($150 a month) from Fortescue shares over the past year, investors would need to own 918 shares in the company.

At the last closing price of $21.57 per share, this would cost an investor $19,801.26.

Dividend estimate

Looking to the future, the team at Bell Potter is tipping Fortescue to pay a larger dividend in the second half of FY23.

Analysts are forecasting Fortescue to pay a fully franked final dividend of 148.8 cents per share this financial year.

If this eventuates, Fortescue would pay a total of 223.8 cents per share in dividends in the 2023 financial year.

To receive $1800 in annual income — or $150 in monthly income — from a 223.8 cents per share dividend, investors would need to own 804 Fortescue shares ($1,800 divided by $2.238).

Therefore, based on the company’s last closing share price of $21.57, investors would need to invest $17,342.28 in Fortescue to generate a monthly income of $150.

Fortescue reported an underlying earnings before interest, tax, depreciation and amortisation (EBITDA) of US$4.352 billion in the first half of FY23, down 8.6% on the prior corresponding half.

Share price snapshot

The Fortescue share price has slipped 0.42% in the last year. However, in the past week, the company’s share price has climbed 1.94%.

Fortescue has a market capitalisation of about $66.4 billion based on its last closing price.

The post Here’s how much I would need to invest in Fortescue shares to generate a $150 monthly income appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Which is the best ASX 200 iron ore stock now: BHP, Fortescue, or Mineral Resources?
• Why did the Fortescue share price smash the ASX 200 in March?
• 2 ASX 200 mining directors buying up their company shares in the past week
• Here are the top 10 ASX 200 shares today
• Bought $9,000 of Fortescue shares in 2018? Here’s how much passive income you’ve pocketed

Motley Fool contributor Monica O’Shea has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/oMHtfEg

The S&P/ASX 200 Index (ASX: XJO) share Medibank Private Limited (ASX: MPL) is expected to pay an increasingly attractive dividend in the next few years.

The ASX healthcare share has been through plenty of difficulties with a cyberattack. However, the Medibank share price has been steadily climbing since hitting a low after the sell-off.

Despite the rise in the share price, the private healthcare business is still projected to pay a sizeable dividend yield this year and beyond.

Ongoing growth

In the recent half-year result, the business saw a number of growth numbers, despite concerns about what could happen after the cyber attack.

It revealed that group net profit after tax (NPAT) rose 5.9% to $233.3 million despite cybercrime costs of $26.2 million, net resident policyholders grew 1,700 (or 0.7%) and net non-resident policy units grew by 33,400 (or 17%). The health insurance operating profit increased 8.7% to $305.2 million. Medibank also increased its interim dividend by 3.3% to 6.3 cents per share.

It said that more normal business operations resumed in January, with “early signs of improvement in policyholder trajectory”. In the month up to 18 February, it saw net growth of 200.

The ASX 200 share also reported that the resident health insurance market remained “buoyant” with growing numbers of younger adults and those taking out cover for the first time despite the challenging economic conditions.

Dividend expectations

According to projections on Commsec, the business is expected to pay an annual dividend per share of 14 cents in FY23. This would be a grossed-up dividend yield of 5.8%.

The dividend could then grow by 11.4% to an annual payment of 15.6 cents per share. This would be a grossed-up dividend yield of 6.5%.

Commsec projections suggest that the ASX 200 share’s dividend could grow by another 2.6% to 16 cents per share in FY25. This would be a grossed-up dividend yield of 6.7%, almost reaching that 7% level.

Foolish takeaway

Dividends are not guaranteed. But, if Medibank can keep increasing its profit then the dividend can keep increasing as well.

The post This ASX 200 share could pay a dividend yield of almost 7% by 2025 appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Medibank share price lifts despite shareholder class action
• Medibank share price slumps as tech boss announces departure
• ‘Increased confidence’: Alphinity reveals 2 ASX 200 shares it just bought
• Latitude shares are back on the ASX, but why are they falling 8% today?
• 2 beaten-up ASX dividend shares I’d buy for long-term income

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/qCRX0PZ

The Arafura Rare Earths Ltd (ASX: ARU) share price has returned from its trading halt with a bang.

In morning trade, the rare earths developer’s shares are up 11% to 53.5 cents.

Why is the Arafura share price racing higher?

Investors have been bidding the Arafura share price higher today after the company announced a major offtake agreement for its Nolans project.

According to the release, the company has signed a binding offtake agreement with Siemens Gamesa Renewable Energy for up to 400 tonnes per annum (tpa) of neodymium and praseodymium (NdPr) metal.

Siemens Gamesa is a pioneer and leader of the wind industry with 27,000 employees.

The deal

The deal is for five years (with an option to extend for two more) and will see offtake volumes start at 200tpa in 2026 before increasing to 360tpa in 2027 and then 400tpa for the following three years. This is in line with the ramp up of the Nolans project.

Management notes that this is the second offtake agreement to be signed, with approximately 53% of its targeted 85% annual production now secured under long-term sale arrangements.

In addition, the company highlights that this offtake agreement will support its ongoing discussions with Germany’s ECA Euler Hermes for an untied loan guarantee of up to US$600 million to support the project.

Arafura’s Managing Director, Gavin Lockyer, commented:

We are delighted to have concluded negotiations for our second offtake agreement. Siemens Gamesa is the world’s leading manufacturer of offshore wind turbines, and this agreement compliments our strategy to create supply diversification into the renewable & E-mobility sectors.

The Arafura share price is now up 52% since this time last year.

The post Here’s why the Arafura share price is racing 11% higher appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why has the Arafura share price just been halted?
• Arafura stock sell-off continues, broker tips 35% upside
• Why Atlantic Lithium, Arafura, Brainchip, and Core Lithium shares are falling

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/gs8JWiZ

The Newcrest Mining Ltd (ASX: NCM) share price is on the move on Tuesday morning.

At the time of writing, the gold miner’s shares are up 6.5% to $30.12.

Why is the Newcrest share price rising?

The Newcrest share price is defying a pullback in the gold price overnight after the company received an improved takeover proposal from US giant Newmont.

Back in February, Newcrest received and rejected an all-scrip offer that was the equivalent of $27.40 per share. This followed the rejection of a previously undisclosed $26.15 per share offer.

The Newcrest board felt that the offer undervalued the company. It explained:

The Board has considered the Indicative Proposal and has unanimously determined to reject the offer as it does not represent sufficient value for Newcrest shareholders.

New offer

This morning, Newcrest revealed that it has received an improved offer of 0.4 Newmont shares per Newcrest share.

In addition, the conditional and non-binding proposal permits Newcrest to pay a franked special dividend of up to US$1.10 per share.

This represents an aggregate implied value of A$32.87 per share, which is a 16% premium to the current Newcrest share price. It also values the company’s equity at $29.4 billion and implies an enterprise value of $32 billion.

The good news for Newmont is that this offer has been enough to get it access to Newcrest’s books. The miner has agreed to grant Newmont the opportunity to conduct confirmatory due diligence to put forward a binding proposal.

However, management has warned that there is no certainty that the revised proposal will result in a binding offer for consideration by shareholders. As a result, shareholders do not need to take any action at this stage.

Newcrest will continue to keep the market informed of any material developments in accordance with its continuous disclosure obligations.

The post Newcrest share price jumps on new takeover offer appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• ASX 200 gold shares are rallying. Is the yellow metal set for new all-time highs?
• Here are the top 10 ASX 200 shares today
• 5 things to watch on the ASX 200 on Friday
• ASX shares are paying out $19 billion in dividends this week. Are you getting a piece?
• Why are ASX 200 gold shares like Newcrest being thumped on Thursday?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/EBvzkg0

The Commonwealth Bank of Australia (ASX: CBA) share price appears to have been caught up in what many have called a global banking crisis.

That saw it tumbling below $100 for the first time since October last year, hitting a 2023 low of $93.05 last month.

So, is the S&P/ASX 200 Index (ASX: XJO)’s biggest bank destined to sit below three figures for now, or is it gearing up to post a ripper recovery? Let’s take a look.

Was the ASX 200 banking giant caught up in international drama?

The CBA share price hasn’t traded over $100 since early March. In the meantime, the global banking sector has faced major disruptions.

United States-based Silvergate Bank kicked off a string of collapses last month, embroiling Silicon Valley Bank and Signature Bank as well. Not to mention, Credit Suisse appeared to be saved from the same fate by an acquisition agreement with Swiss peer UBS.

No doubt, all that shook some investors’ confidence in the sector, thereby weighing on shares in the likes of CBA.

But experts remain divided on whether things could be about to turn around for the biggest of the big four banks.

Will the CBA share price surpass $100?

CBA shares currently trade with a 4.2% dividend yield, a 17.15 price-to-earnings (P/E) ratio, and a 2.31 price-to-book (P/B) ratio, according to CommSec.

That makes the stock the most expensive of its big four banking peers on a P/E and P/B basis. It also offers the lowest dividend yield of the lot.

But Fairmont Equities’ Michael Gable believes the stock is worth the premium. The expert tips the bank to outperform over the long term due to its quality, as per The Bull.

Meanwhile, broker UBS has a $100 price target on CBA shares while Morgans expects the stock to slump to $96.11.

Personally, I think the CBA share price is likely to bounce into triple-digits in the near future. Indeed, it’s less than 1% off the milestone figure right now.

However, only time will tell if the stock can both surpass $100 and remain there, over the long term.

The post Is the CBA share price heading back over $100? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Could right now be a great time to buy ASX 200 bank stocks for passive income?
• Investing in ASX 200 dividend shares? Here’s how I’d aim for $200 per month in passive income
• Is right now a once-in-a-decade opportunity to buy CBA shares?
• ASX 200 rebounds after RBA hits pause on its rate hikes
• Passive income: How much to invest to get $800 per month

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/0z7FONw